Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 1
2020 6
2021 6
2022 6
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
Széles Á, Fazekas T, Váncsa S, Váradi M, Kovács PT, Krafft U, Grünwald V, Hadaschik B, Csizmarik A, Hegyi P, Váradi A, Nyirády P, Szarvas T. Széles Á, et al. Among authors: csizmarik a. Cancer Immunol Immunother. 2023 May;72(5):1061-1073. doi: 10.1007/s00262-022-03328-9. Epub 2022 Nov 16. Cancer Immunol Immunother. 2023. PMID: 36385210 Free PMC article. Review.
Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer. A Systematic Review and Meta-analysis.
Fazekas T, Széles ÁD, Teutsch B, Csizmarik A, Vékony B, Kói T, Ács N, Hegyi P, Hadaschik B, Nyirády P, Szarvas T. Fazekas T, et al. Among authors: csizmarik a. Eur Urol Oncol. 2023 Sep 16:S2588-9311(23)00174-8. doi: 10.1016/j.euo.2023.09.001. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37722977 Free article. Review.
COVID-19 research: promising tracks leading to uro-oncology.
Tamás F, Tibor S, Anita C, Boris H, Péter N. Tamás F, et al. Among authors: anita c. Int Urol Nephrol. 2020 Jun;52(6):995-997. doi: 10.1007/s11255-020-02490-2. Epub 2020 May 11. Int Urol Nephrol. 2020. PMID: 32394243 Free PMC article. No abstract available.
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas.
Varadi M, Nagy N, Reis H, Hadaschik B, Niedworok C, Modos O, Szendroi A, Ablat J, Black PC, Keresztes D, Csizmarik A, Olah C, Gaisa NT, Kiss A, Timar J, Toth E, Csernak E, Gerstner A, Mittal V, Karkampouna S, Kruithof de Julio M, Gyorffy B, Bedics G, Rink M, Fisch M, Nyirady P, Szarvas T. Varadi M, et al. Among authors: csizmarik a. Cancer Med. 2023 Apr;12(7):9041-9054. doi: 10.1002/cam4.5639. Epub 2023 Jan 20. Cancer Med. 2023. PMID: 36670542 Free PMC article.
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysis.
Fazekas T, Széles ÁD, Teutsch B, Csizmarik A, Vékony B, Váradi A, Kói T, Lang Z, Ács N, Kopa Z, Hegyi P, Hadaschik B, Grünwald V, Nyirády P, Szarvas T. Fazekas T, et al. Among authors: csizmarik a. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):665-672. doi: 10.1038/s41391-022-00626-2. Epub 2022 Dec 12. Prostate Cancer Prostatic Dis. 2023. PMID: 36509931 Free PMC article. Review.
Comprehensive Analysis of the Prognostic Value of Circulating MMP-7 Levels in Urothelial Carcinoma: A Combined Cohort Analysis, Systematic Review, and Meta-Analysis.
Kubik A, das Virgens IPA, Szabó A, Váradi M, Csizmarik A, Keszthelyi A, Majoros A, Fehérvári P, Hegyi P, Ács N, Nyirády P, Szarvas T. Kubik A, et al. Among authors: csizmarik a. Int J Mol Sci. 2023 Apr 26;24(9):7859. doi: 10.3390/ijms24097859. Int J Mol Sci. 2023. PMID: 37175566 Free PMC article. Review.
24 results